Marko Salmi
About
In The Last Decade
Marko Salmi
199 papers receiving 10.5k citations
Peers
Comparison fields: 5 of 135
- Molecular Biology 4.7k
- Immunology 3.5k
- Oncology 1.9k
- Cell Biology 1.3k
- Epidemiology 1.2k
Countries citing papers authored by Marko Salmi
This map shows the geographic impact of Marko Salmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Salmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Salmi more than expected).
Fields of papers citing papers by Marko Salmi
This network shows the impact of papers produced by Marko Salmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Salmi. The network helps show where Marko Salmi may publish in the future.
Co-authorship network of co-authors of Marko Salmi
This figure shows the co-authorship network connecting the top 25 collaborators of Marko Salmi. A scholar is included among the top collaborators of Marko Salmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Salmi. Marko Salmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 15 | |
| 4 | 11 | |
| 5 | 21 | |
| 6 | 37 | |
| 7 | 19 | |
| 8 | 86 | |
| 9 | 77 | |
| 10 | 16 | |
| 11 | Early Prediction of Persistent Organ Failure by Soluble CD73 in Patients With Acute Pancreatitis | 2 |
| 12 | 7 | |
| 13 | 113 | |
| 14 | 57 | |
| 15 | Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1(+)CD11b(+) Myeloid Cells into Tumors | 1 |
| 16 | 16 | |
| 17 | 23 | |
| 18 | 100 | |
| 19 | 43 | |
| 20 | 40 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.